Home
Search results “Promining therapeutics san diego”
Therapeutic Vaccine for HIV
 
03:37
NIAID scientists are testing a therapeutic vaccine for HIV in people.
Views: 16815 NIAID
Century-Old Drug Tested in Boys with Autism
 
05:45
Suramin is a 100-year-old drug developed to treat African sleeping sickness. It is not approved for any therapeutic use in the U.S. However, a small clinical trial at UC San Diego School of Medicine found that a single intravenous dose of suramin produced measurable, but transient, improvements in five boys with autism spectrum disorder (ASD). More broadly, the trial findings support the “cell danger response theory,” which posits that autism is driven by metabolic dysfunction — and thus treatable. Larger, longer clinical trials are needed to assess suramin as an ASD treatment. In this video we hear from lead researcher Robert Naviaux, MD, PhD, and the mothers of two boys who received suramin in the trial. For more, visit http://health.ucsd.edu/suramin
Views: 12811 UC San Diego Health
New Therapies that Target the JAK-STAT Pathway and other Small Molecules
 
16:48
Dedicated to the interests of the entire community of patients with inflammatory bowel disease (IBD), and designed to meet the educational needs of all healthcare professionals who treat and manage patients with IBD, 2015 Advances in Inflammatory Bowel Diseases: Crohn's & Colitis Foundation's Clinical and Research Conference is the foremost event for investigators and healthcare professionals to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with IBD. In this presentation, Dr. William J. Sandborn discusses new therapies that target the JAK-STAT pathway, as well as other small molecules. Earn accreditation for this activity at the following location: http://elc.imedex.com/elc/activity-search.aspx?search=2015AIBDWEBCAST © 2016 Imedex, LLC.
Views: 1712 ImedexCME
Batu Biologics Mechanism of Action Animation for ValloVax Immunotherapy
 
03:12
Batu Biologics is a San Diego based biotechnology company focused on researching the observed parallels between pregnancy and cancer. Our lead therapeutic is a naturally derived placental based immunotherapy designed to train your body to attack several pathways that drive blood vessel formation within tumors. The Company has recently received clearance of its Investigational New Drug application (#16296) enabling the Company to proceed with human clinical studies to evaluate the safety and immune response of the immunotherapy in patients with advanced lung cancer. For more information please visit our website at www.batubiologics.com
Views: 5034 Batu Biologics
NAFLD/NASH: Anticipating an impending storm - vostfr
 
19:15
In this educational video, international renowned Key Opinion Leaders address NAFLD (non alcoholic fatty liver disease), and more especially NASH (non-alcoholic steatohepatitis) and its main challenges. --- Dans cette vidéo éducative plusieurs leaders d'opinion reconnus internationalement nous parlent des NAFLD (non alcoholic fatty liver diseases), et plus particulièrement de la NASH (stéatohépatite non-alcoolique ou "maladie du soda") et de ses principaux challenges. --- Guest speakers: Stephen A. Harrison, MD Medical Director of Pinnacle Clinical Research Visiting Professor of Hepatology at the Radcliffe College of Medicine, University of Oxford, San Antonio, Texas Marie E. Rinella, MD Associate Professor of Medicine, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois – USA Arun J. Sanyal, MD Professor Internal Medicine Department of Gastroenterology Virginia Commonwealth University Medical Center, Richmond, Virginia Kenneth Cusi, MD Professor of Medicine Chief, Division of Endocrinology, Diabetes and Metabolism The University of Florida Gainesville, Florida Vlad Ratziu, MD Professor of Hepatology Hôpital Pitié Salpêtrière, Institute of Cardiometabolism and Nutrition Paris, France
Sorrento Therapeutics developing new treatments for cancer and associated pain
 
03:03
Sorrento Therapeutics (NASDAQ:SRNE) - developing new treatments for cancer and associated pain.
NASH: Anticipating an impending storm - Part 1/5 - What is NASH? - The silent threat - vostfr
 
05:30
In this first part, Stephen A. Harrison, MD, Medical Director of Pinnacle Clinical Research, San Antonio, introduces us to NAFLD (Non Alcoholic Fatty Liver Disease), and more specifically NASH (Non-alcoholic Steatohepatitis). He explains the definition of the disease, as well as its characteristics & the risks induced by its progression. He also highlights how the disease is related to the double epidemic of obesity and diabetes. --- Dans cette première partie, Stephen A. Harrison, MD, Directeur Médical du Pinnacle Clinical Research, San Antonio, nous présente la NAFLD (Non Alcoholic Fatty Liver Disease), et plus particulièrement la NASH (Stéatohépatite Non-Alcoolique ou "maladie du soda"). Il nous explique la définition de la maladie, ses caractéristiques ainsi que les risques liés à sa progression. Il met également en lumière le lien entre cette pathologie et la double épidémie d'obésité et de diabète.
NBC features Toca 511 delivery in patient with glioblastoma at UC San Diego Moores Cancer Center
 
03:05
A NBC reporter interviews patient Berm, who was given a prognosis of six months after being diagnosed with recurrent brain cancer, but two years later was still doing well. He shares more about his quality of life and how the treatment makes him feel. Dr. David Piccioni, neuro-oncologist at UC San Diego also explains how the viral therapy is designed to work. Learn more about Tocagen’s clinical trials here: http://tocagen.com/patients/clinical-trials/toca-five-clinical-trials/ Subscribe to Tocagen: https://goo.gl/EGb8E3 Like us on Facebook: https://www.facebook.com/Tocagen/ Follow us on Twitter: @Tocagen Toca 511 & Toca FC is an investigational therapy, which has not been proven to be safe or effective for any use and is not approved by the U.S. Food and Drug Administration or any other government agency.
Views: 4970 Tocagen
Promising Paths: An Interview with a Former Pathmaker Intern - Daniel Sykora, Medical Student
 
08:24
Pathmaker Interns serve alongside health care professionals in many facets of the industry, working together to provide patient support under the guidance of staff in the provision of a safe, comfortable and confidential environment. For more information about the program: http://bit.ly/ZqUz0B
Views: 573 Palomar Health
Skin Regeneration Gene Therapy at RAADfest | Dr. Brad Thompson and James Strole
 
07:25
James Strole, Director of the Coalition for Radical Life Extension, organizer of RAADfest, and Dr. Brad Thompson, CEO of Wyvern Pharmaceuticals Inc., tease skin and organ regeneration gene therapy to be presented at RAADfest 2018. Results on an ongoing, funded study will be presented at the 3rd annual RAADfest, in San Diego, CA. --Learn more and register for RAADfest 2018 today: http://www.raadfest.com/ -Learn more about the study: https://wyvernpharma.com/ -Learn more about the Coalition: http://www.rlecoalition.com/ The Coalition for Radical Life Extension is a non-profit organization.
Galectin Therapeutics (NasdaqCM: GALT): Money Report Interview
 
06:04
Dave Gentry interviews Jim Czirr, executive chairman of Galectin Therapeutics (NasdaqCM: GALT). Galectin Therapeutics is a developer of promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, key mediators of biologic function. "The RedChip Money Report"™ delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. The weekly program airs on Fox Business as well as My Family TV and TUFF TV. For more information, visit: http://www.redchip.com/tv
Views: 1552 RedChip Companies
From the Human Genome Project to Precision Medicine: A Journey to Advance Human Health
 
01:36:56
Summer Lecture Series I: From the Human Genome Project to Precision Medicine: A Journey to Advance Human Health Air date: Wednesday, July 11, 2018, 2:00:00 PM Category: Career Development/OITE Runtime: 01:36:55 Description: From the Human Genome Project to Precision Medicine: A Journey to Advance Human Health For more information go to https://www.training.nih.gov/events/view/_2/2339/Summer_Lecture_Series_I_Dr_Eric_Green Author: Eric D. Green, MD, PhD, Director, National Human Genome Research Institute Permanent link: https://videocast.nih.gov/launch.asp?23992
Views: 708 nihvcast
Acute Spinal Cord Injury: Devastating but Treatable Disorder
 
01:00:13
Dr. Edward Hall, director of the University of Kentucky's Spinal Cord and Brain Injury Research Center, outlines the pathophysiology of spinal cord injury and discusses promising single and multi-drug therapeutic approaches for improving neurological outcomes.
Views: 19350 ResearchChannel
New Mechanistic Insights into Inflammation Triggered by Invasive Infection
 
01:05:18
Sounding the Alarm and Putting Out the Fire: New Mechanistic Insights into Inflammation Triggered by Invasive Infection Air date: Wednesday, May 30, 2018, 3:00:00 PM Category: WALS - Wednesday Afternoon Lectures Runtime: 01:05:18 Description: NIH Director’s Wednesday Afternoon Lecture Series The Lieberman laboratory has been in the forefront of developing RNAi-based therapeutics and using RNAi for genome-wide screening. The lab was the first to demonstrate that siRNAs could protect mice from disease. Dr. Lieberman and her lab developed methods to harness RNAi to inhibit herpes and HIV transmission in animal models. They have developed strategies for cell-targeted RNAi to treat viral infection, immune disease, and cancer. They are currently investigating tumor-targeted siRNAs for immunotherapy to activate tumor expression of neoantigens and avoid autoimmune side effects of checkpoint inhibitors. The lab is also investigating the role of endogenous microRNAs and lncRNAs in regulating cell differentiation and cancer. In particular, Dr. Lieberman and her colleagues study cytotoxic T lymphocytes and their role in infection and tumor immunity. Her lab investigates the molecular pathways used by killer lymphocytes and their cytotoxic granule proteases (granzymes) and pore-forming proteins (perforin and granulysin) to induce programmed cell death. The lab has defined a caspase-independent programmed-cell-death pathway activated by granzyme A. Recent work has identified an unexpected role for granzymes and granulysin: protecting against bacteria and parasites. Dr. Lieberman and her lab recently uncovered the molecular basis for inflammatory cell death (pyroptosis) triggered by invasive bacteria and other danger signals. They found that the inflammatory caspase-cleaved protein (gasdermin D) causes cell death due to the formation of membrane pores. This mechanism also directly kills the bacteria that trigger the inflammasome. Current work focuses on innate and adaptive immune responses to invasive pathogens, including bacteria, malaria, other parasites, and fungi, including the role of decidual natural killer cells in protection against infection in pregnancy. This Khoury lecture was organized by NIH scientists to honor the memory of cancer virologist George Khoury, M.D., who was highly regarded as a superb scientist and caring mentor of the postdoctoral fellows in his laboratory. Dr. Khoury, former chief of the Laboratory of Molecular Virology at the National Cancer Institute, was known for his instinctive inquisitive nature, unfaltering kindness, self-giving mentorship, and exceptional science. For more information go to https://oir.nih.gov/wals Author: Judy Lieberman, M.D., Ph.D., Chair in Cellular and Molecular Medicine, Program in Cellular and Molecular Medicine, Boston Children's Hospital; Professor of Pediatrics, Harvard Medical School Permanent link: https://videocast.nih.gov/launch.asp?23924
Views: 470 nihvcast
The Exit Drug | Full Documentary
 
15:40
The Exit Drug documentary, created by Weedmaps, investigates how cannabis could play a major role in ending the opioid crisis, a public health emergency that kills an average of 115 U.S. citizens a day. According to neuroscientist Dr. Adie Wilson-Poe, cannabis has the potential to significantly improve public health by diminishing our reliance on opioids. The Exit Drug explores the course of opioid addiction, from initial usage (typically after an injury) to drug relapse, and how cannabis could be the solution to reduce harm and promote help. Learn more about The Exit Drug: http://weedma.ps/ExitDrug. Can't get enough? Weedmaps Facebook: http://weedma.ps/FacebookYT Weedmaps Twitter: http://weedma.ps/TwitterYT Weedmaps Instagram: http://weedma.ps/InstaYT Weedmaps Skate Instagram: http://weedma.ps/SkateYT Weedmaps Surf instagram: http://weedma.ps/SurfYT Weedmaps BMX Instagram: http://weedma.ps/BMXYT Weedmaps Moto Instagram: http://weedma.ps/MotoYT About Weedmaps: Weedmaps is the world’s first marijuana technology and media brand. Since 2008, Weedmaps.com has helped medical marijuana patients and adult recreational users find the doctor’s, dispensaries, retail stores, delivery services, menus, and deals near them. With close to 8,000 listings, Weedmaps is the largest directory of medical and adult use marijuana in the world. Weedmaps TV https://www.youtube.com/WeedmapsTV
Views: 32247 Weedmaps
A breakthrough for oral mucositis management with avisopasem manganese
 
03:04
Locally advanced head and neck cancer is treated with chemotherapy and radiation as standard, with an aim to cure the disease. Unfortunately, this therapy is associated with severe toxicity, primarily in the form of oral mucositis. In this video, recorded at the at the American Society of Oncology (ASCO) 2018 Annual Meeting in Chicago, IL, Ezra Cohen, MD, FRCPC, FASCO, of the University of California, San Diego, CA, discusses a recent randomized trial (NCT02508389) which tested the impact of avisopasem manganese vs. a placebo on oral mucositis. The results were very promising: severe mucositis lasted an average of 3 weeks with the placebo, and only 1.5 days with the drug. Dr Cohen emphasizes the importance of this breakthrough for patient quality of life, and looks to future Phase III studies which will progress this research.
Views: 19 VJOncology
A Promising New Brain Cancer Research Trial
 
02:41
On December 19, 2013, Accelerate Brain Cancer Cure interviewed Fritz Anderson about the brain cancer clinical trial he is participating in at Duke. Mr. Anderson was diagnosed with a glioblastoma multiforme, the most aggressive form of brain cancer. He is one of ten patients participating in the Phase 1 Poliovirus Vaccine clinical trial at Duke. ABC2 was an early funder of this research.
Genomic Advances in Drug Discovery & Development - Lon Cardon, Ph.D.
 
49:31
Dr. Cardon joined GlaxoSmithKline in 2008, initially as head of Genetics. He is now head of Alternative Discovery and Development, a pan-therapeutic division focused on nontraditional approaches for drug discovery and development.
Views: 782 Mayo Clinic
LaDainian Tomlinson Breaks Single-Season TD Record vs. Broncos (Week 14, 2006) | NFL Full Game
 
01:56:44
In honor of Free Game Friday the NFL presents LT's record breaking day! 14:58 - Philip Rivers finds Antonio Gates in the end zone for 12-yard TD pass 23:11 - Chargers score touchdown off ‘Bumerooski’ nifty trick play for Lorenzo Neal 25:24 - Broncos’ Tatum Bell explodes for 51-yards on rush 27:32 - Broncos’ Jason Elam scores 34-yard FG 31:14 - LaDainian Tomlinson scores TD on 1-yard rush 48:53 - Rivers lobs 7-yard TD pass to Antonio Gates 59:26 - Jay Cutler throws 28-yard TD pass to Tony Scheffler 1:00:32 - Chargers fumble on ensuing kickoff, recovered by Denver 1:03:40 - Jay Cutler finds Tony Scheffler for his 2nd TD of the game 1:18:42 - Jason Elam makes 33-yard FG to bring Broncos within 8 points 1:24:35 - Nate Kaeding makes 34-yard FG 1:29:43 - Chargers stop Broncos on 4th down 1:34:41 - Nate Kaeding makes 35-yard FG 1:38:00 - Chargers sack Jay Cutler on 4th down 1:42:53 - LaDainian Tomlinson ties the season Rush TD record 1:46:10 - Shawn Merman strip-sacks Jay Cutler and Chargers recover 1:49:54 - LaDainian Tomlinson sets season Rush TD record at 29 on the season The Chargers late season blowout win over the Broncos helped them secure the top seed in the AFC conference and keep Denver out of the playoffs. LaDainian Tomlinson led the way for the Chargers, notching three touchdowns and 103 yards, which set the NFL single season touchdown record. Subscribe to NFL: http://j.mp/1L0bVBu The NFL YouTube channel is your home for immediate in-game highlights from your favorite teams and players, full NFL games, behind the scenes access, up-to-the-minute analysis and more! Check out our other channels: NFL Network http://www.youtube.com/nflnetwork NFL Films http://www.youtube.com/nflfilms For all things NFL, visit the league's official website at http://www.nfl.com/ Start your free trial of NFL Game Pass: https://www.nfl.com/gamepass Fantasy Football: http://www.nfl.com/fantasyfootball Watch NFL Now: https://www.nfl.com/now Listen to NFL podcasts: http://www.nfl.com/podcasts Watch the NFL network: http://nflnonline.nfl.com/ Download the NFL mobile app: https://www.nfl.com/apps 2016 NFL Schedule: http://www.nfl.com/schedules Buy tickets to watch your favorite team: http://www.nfl.com/tickets Shop NFL: http://www.nflshop.com/source/bm-nflcom-Header-Shop-Tab Like us on Facebook: https://www.facebook.com/NFL Follow us on Twitter: https://twitter.com/NFL Follow us on Instagram: https://instagram.com/nfl/
Views: 69518 NFL
Overview of CLL therapies and sequencing of therapies
 
09:00
Jacqueline Barrientos, MD of Northwell Health Cancer Institute, Lake Success, NY gives an overview of chronic lymphocytic leukemia (CLL) therapies and sequencing of therapies at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA. Dr Barrientos explains the importance of taking into account patient characteristics at the time of therapy; before therapy is started, it is important to check for TP53 mutation and 17p deletion as it affects the choice of therapy. For patients who do not tolerate ibrutinib, venetoclax is now available for patients with a 17p deletion or TP53 mutation; she also mention the use of idelalisib for this indication. For patients without these mutations, therapy choice depends on their characteristics and particularly their fitness. If they are fit, regimens such has fludarabine, cyclophosphamide, rituximab (FCR) should be considered. She further explains the complications associated with FCR therapy and explains the alternative, i.e. bendamustine-rituximab (BR). A trial that has finished accrual will compare FCR against ibrutinib in combination with rituximab and another trial will look at BR against ibrutinib in combination with rituximab or as monotherapy. She further explains the issues with targeted therapy, i.e. the question of discontinuation, and discusses the combinations of obinutuzumab with chlorambucil and ofatumumab with chlorambucil. She then outlines considerations behind sequencing therapies, including options for patients who relapse within the first three years and patients treated with tyrosine kinase inhibitors (TKIs). Further, she discusses data presented at ASH 2016 by Anthony Mato on venetoclax, ibrutinib and idelalisib and data on acalabrutinib and other new agents that are in the pipeline.
Alcoholism Part 2 - LastingRecovery.com - San Diego - Judy Saalinger
 
19:01
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 2 of a 3-part Audio Program focusing on ALCOHOLISM, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 181 Lasting Recovery
Changing Strategies in the War on Cancer (3): Improving Outcomes in the Treatment of Breast Cancer
 
34:33
Over the last 25 years, there has been an explosion of new and vitally important, anticancer drugs. The development of these promising new therapeutic agents is generally based on pre-clinical and clinical research. In many cases, this research has become prohibitively expensive. And only a relatively few investigational drugs have reached the market and successfully improved clinical outcomes in the treatment of patients with cancer and hematological malignancies. In the development of new therapies, the traditional clinical trial process of determining which drugs will ultimately benefit patients is long and expensive. Over the last few decades scientists have tried to change – and improve – the way clinical trials are conducted. Their purpose… Improving the process and improving the way novel pharmaceutical drugs are being developed. But it still takes many years and huge investments to successfully bring a new drug to market. But despite their efforts there is still a huge unmet medical need. While there are many novel drugs being developed to help improve the outcome and improve survival, resources are limited. Optimal use of resources requires better understanding of cancer biology, the identification of novel therapeutic targets, and the ability to address inefficiencies in the cancer clinical trials system. This may especially be so in how we treat women with metastatic, high risk, breast cancer. Based on the current limitations in how we conduct clinical trials, scientists of The Biomarkers Consortium, at the Foundation for the National Institutes of Health, are changing the way new anticancer drugs are being developed. The Foundation’s unique and groundbreaking, re-engineered approach to clinical trials is the I-SPY Clinical Trial. This trial represents an unprecedented and streamlined method in developing new anticancer drugs. Using breast cancer treatment as a model – the I-SPY TRIALs are designed to significantly reduce the overall cost, time, and number of patients required to bring innovative anticancer agents to the right patient at the right time – and do this faster. The I-SPY Trial Program integrates and links Phase I, Phase II and eventually Phase III clinical oncology trials to build a pipeline of novel anticancer agents. As a result, the new trial program accelerates the process of identifying a subset of high risk breast cancer patients that will directly benefit from these novel agents. Among the targeted drugs being investigated in the I-SPY 2 trail are antibody-drug conjugates or ADCs. Antibody-drug Conjugates are part of a new wave of targeted antibody-based products. They are novel, innovative agents at the cutting edge of oncology and hematology. During the Annual Meeting of the American Association of Cancer Research, held – April 16 – 20, 2016, in New Orleans, we sat down with Doctor Angela DeMichele, Professor of Medicine and Epi-demi-ology at the Perelman School of Medicine at the University of Pennsylvania. We asked Doctor DeMichele a number of questions about a specific part of the I-SPY-2 trial in which researchers investigated a particular antibody-drug conjugate and how a combination of drugs, including antibody-drug conjugates, can bring a substantially greater proportion of patients to the primary endpoint of pathological complete response or PCR, an outcome in which, following neoadjuvant therapy, residual invasive cancer is detected in the breast tissue and lymph nodes during surgery. And we asked her about the benefit of targeted therapy and how novel drugs like antibody-drug conjugates play a role.
Letting Go - LastingRecovery.com
 
02:13
Judy Saalinger, Co-Founder and Executive Director of San Diego's premier alcohol and drug addiction treatment center Lasting Recovery, explains what "Letting Go" is all about. For more information visit lastingrecovery.com, or call 858-453-4315. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 498 Lasting Recovery
If You Live With Or Love An Alcoholic - LastingRecovery.com - Judy Saalinger
 
02:17
Judy Saalinger, Co-Founder and Executive Director of San Diego's premier alcohol and drug addiction treatment center Lasting Recovery, discusses "Questions People Need To Ask Themselves If They Live With or Love An Alcoholic". For more information visit lastingrecovery.com, or call 858-453-4315. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 2416 Lasting Recovery
Early treatment and novel therapeutic targets for multiple myeloma
 
10:48
At the Myeloma 2015 meeting, Dr Keith Stewart (Mayo Clinic, Scottsdale, AZ) chairs a discussion with Prof Jesús San Miguel (University of Salamanca, Salamanca, Spain) and Prof Antonio Palumbo (University of Torino, Torino, Italy) on new studies of the role of early intervention for smoldering multiple myeloma (MM), treatment strategies for high-risk MM, and promising novel agents for MM.
Alcoholism Part 3 - LastingRecovery.com - San Diego - Judy Saalinger
 
17:33
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 3 of a 3-part Audio Program focusing on ALCOHOLISM, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 90 Lasting Recovery
Chronic Pain & Opiate Dependence Part 3 - LastingRecovery.com - San Diego - Judy Saalinger
 
18:09
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 3 of a 3-part Audio Program focusing on Chronic Pain & Opiate Dependency, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 285 Lasting Recovery
Will CRISPR Gene Editing Help Treat Autism Someday?
 
01:08
Digital Trends reports that scientists may soon be able to treat autism with CRISPR gene editing. Researchers at UC Berkeley and other institutes may have discovered this new application. The CRISPR-Cas9 gene editing has proven its use in a variety of ways. From creating more efficient crops to malaria-resistant mosquitoes. But now there's a possibility that it may help edit out genetic traits associated with autism. It’s only been used on mice so far, but a paper recently published shows the massive potential. The research was published in the journal Nature Biomedical Engineering. The process described could revolutionize autism treatment for millions around the world. “This study shows the first time demonstration of the rescue autistic symptoms using gene editing in autism mouse model... On the top of that, we used nonviral way to deliver to do it, which supports the potential therapeutic treatment for brain disorders.” Hye Young Lee, University of Texas Health Science Center at San Antonio https://www.digitaltrends.com/cool-tech/crispr-gene-editing-autism/ http://www.wochit.com This video was produced by YT Wochit Tech using http://wochit.com
Views: 106 Wochit Tech
Chronic Pain & Opiate Dependence Part 1 - LastingRecovery.com - Judy Saalinger
 
15:32
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 1 of a 3-part Audio Program focusing on Chronic Pain & Opiate Dependence, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 705 Lasting Recovery
3 Rules That Govern The Family System In Addiction - LastingRecovery.com
 
05:01
Judy Saalinger, Co-Founder and Executive Director of San Diego's premier alcohol and drug addiction treatment center Lasting Recovery, discusses "3 Rules That Govern The Family System In Addiction"". For more information visit lastingrecovery.com, or call 858-453-4315. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 9813 Lasting Recovery
Altogen Labs Raji Xenograft Service Lymphoma
 
00:40
Altogen Labs http://altogenlabs.com provides xenograft services http://altogenlabs.com/xenograft-models/lymphoma-xenograft/raji-xenograft-model/. The human lymphoblastoid Raji cell line was derived from an 11-year-old black male patient with Burkitt’s lymphoma and is considered the first hematopoietic human cell line. In addition to being a suitable transfection host for molecular biology applications, Raji cells are resistant to some viruses such as vesicular stomatitis and polio. The Raji human lymphoma cell line is used to create the CDX (Cell Line Derived Xenograft) Raji xenograft mouse model that promotes tumor growth inhibition studies by immunotoxins and antibody-based therapies such as anti-CD20Fab-LDM and heparanase-neutralizing monoclonal antibodies. The Raji xenograft model is useful for biomedical research related to lymphoma. Xenografting is the transplantation of tissue from one species into another. Xenografting has been established as benchmark studies in pre-clinical cancer research. Typically, immunodeficient mice serve as hosts for a wide variety of human tumors, effectively serving as models for human subjects. Xenografting is a complete and accurate study of tumor growth and the activity of drug administration. -Raji Xenograft Model Sample Cell Lines Available -Raji Xenograft Model Advantages of Xenografting Develop new therapeutic agents quickly, efficiently and cost-effectively Evaluate the efficacy and toxicity of potential therapeutic agents Evaluate target compound activity using in vivo system (human cells) Predict cytotoxicity of cancer drugs -Raji Xenograft Model Basic Xenograft Study Xenograft studies can be designed to: Identify lead compounds Optimize dose schedules Identify combination strategies -Raji Xenograft Model Routes of drug administration: Intratumoral Intramuscular Oral gavage Intravenous Intratracheal Subcutaneous Intraperitoneal Continuous infusion Intranasal Using cutting-edge micro-injection techniques -Raji Xenograft Model Following options are available for the Raji xenograft model: Raji Tumor Growth Delay (TGD; latency) Raji Tumor Growth Inhibition (TGI) Dosing frequency and duration of dose administration Raji tumor immunohistochemistry Alternative cell engraftment sites (orthotopic transplantation, tail vein injection and left ventricular injection for metastasis studies, injection into the mammary fat pad, intraperitoneal injection) Blood chemistry analysis Toxicity and survival (optional: performing a broad health observation program) Gross necropsies and histopathology Positive control group employing cyclophosphamide, at a dosage of 50 mg/kg administered by intramuscular injection to the control group daily for the study duration Lipid distribution and metabolic assays Imaging studies: Fluorescence-based whole body imaging, MRI -Raji Xenograft Model Altogen Labs’ team of scientists carries extensive experience in Xenograft model research. Altogen Labs is compliant as a Good Laboratory Practices (GLP) environment, which is required by the FDA for pre-clinical research. Our Altogen Labs’ Xenograft services are extensive, rigorous, and flexible. Contact us to discuss Xenograft model details, timeline estimates, and price quotes! Connect to Altogen Labs: LinkedIn - https://www.linkedin.com/company/altogen-labs/ Twitter - https://twitter.com/altogen?lang=en Facebook - https://www.facebook.com/Altogen.CRO/
Views: 897 Altogen Labs
Relapse to nicotine seeking behavior  neurobiology, animal models, and promising anti nicotine med
 
12:53
“Relapse to nicotine-seeking behavior – neurobiology, animal models, and promising anti-nicotine medications” Eliot Gardner, Ph.D. Chief, Neuropsychopharmacology Section, National Institute on Drug Abuse (NIDA) Athina Markou Memorial Symposium Thursday, November 10, 2016 Atkinson Hall, UC San Diego On behalf of the UCSD Department of Psychiatry, we welcome you to the Athina Markou Memorial Symposium. Professor Markou was a uniquely gifted scientist, caring mentor, dedicated Greek, fearless adventurer, and loving friend and partner. Born in Greece, Athina came to the U.S. for graduate training, first in Cincinnati and then UCSD. At The Scripps Research Institute and then UCSD, Dr. Markou established a world-class laboratory focusing on the neurobiology of reward and motivational processes relevant to psychiatric disorders. She trained exceptional scientists, mentoring 70+ young investigators, many becoming leaders in the field. As Vice Chair for Basic Science Research in Psychiatry, she was a vibrant leader who fostered the recruitment of new basic sciences faculty, helped organize our Research Council, and established a very successful research colloquium series. Dr. Markou sought to develop new therapeutics for addiction and mood disorders. She designed ways to quantitatively measure reward and motivational processes characterizing psychostimulant dependence in rodents, providing the field with important tools. Her pioneering work on metabotropic glutamate receptors led to clinical trials of mGlu2 positive allosteric modulators in tobacco dependence. She also led a multidisciplinary team to develop GABA-B receptor modulators for treating nicotine dependence. Dr. Markou’s pioneering work was recognized by the American College of Neuropsychopharmacology, via the Daniel H. Efron Research Award. Dr. Markou authored 200+ articles and reviews, which are widely cited in the literature. She was a tireless contributor to the field as editor for top psychopharmacology journals, receiving multiple awards for her dedication to the peer-review process. She took special pride in her work with the Greek Neuroscience community, and was featured by Deree College in Athens, her undergraduate alma mater, as a “success story” in Greek newspapers.
Views: 75 Calit2ube
Family Recovery From Substance Abuse - Part 1 - LastingRecovery.com - with Judy Saalinger
 
16:35
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 1 of a 2-part Audio Program focusing on Family Recovery, with Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 450 Lasting Recovery
I Understand - LastingRecovery.com - Judy Saalinger
 
01:43
Judy Saalinger, Co-Founder and Executive Director of San Diego's premier alcohol and drug addiction treatment center Lasting Recovery, shares her personal story in: "I Understand" For more information visit lastingrecovery.com, or call 858-453-4315. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 271 Lasting Recovery
Parkinson’s Disease: New Developments and Therapies  - On Our Mind
 
14:04
(Visit: http://www.uctv.tv/) Approximately 1 million Americans currently live with Parkinson’s disease. Irene Litvan, MD joins our host William Mobley, MD, PhD to discuss the latest advances in PD research. Learn about the progression of the disease, early warning signs, and promising new therapies currently in development. Series: "Women in Science" [1/2016] [Health and Medicine] [Science] [Show ID: 30021]
Marijuana: Is it addicting? Part 2 - LastingRecovery.com - San Diego - Judy Saalinger
 
23:11
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 2 of a 3-part Audio Program focusing on MARIJUANA: Is It Addicting?, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 211 Lasting Recovery
Peter Attia, M.D. on Macronutrient Thresholds for Longevity and Performance, Cancer and More
 
01:03:26
Dr. Peter Attia is a medical doctor founder of Attia Medical, PC a medical practice with offices in San Diego and New York City, that focuses on the applied science of longevity and optimal performance. In addition to being a medical doctor, Dr. Attia has done research on the role of regulatory T cells in cancer regression and other immune-based therapies for cancer. Regulatory T cells have also been, in the past, referred to as suppressor T cells because of their role in actually attenuating or reducing the inflammatory response. ▶︎ Get the show notes and transcript! https://www.foundmyfitness.com/episodes/peter-attia Links related to Dr. Peter Attia: ▶︎ Visit Dr. Attia's Website: http://www.attiamedical.com/ ▶︎ Dr. Attia on Twitter: https://twitter.com/PeterAttiaMD ▶︎ Dr. Attia on Facebook: https://www.facebook.com/eatingacademy/ Links related to FoundMyFitness: ▶︎ Subscribe on YouTube: https://www.youtube.com/user/FoundMyF... ▶︎ Join my weekly email newsletter: http://www.foundmyfitness.com/?sendme... ▶︎ Crowdfund more videos: http://www.patreon.com/foundmyfitness ▶︎ Subscribe to the podcast: http://itunes.apple.com/us/podcast/fo... ▶︎ Twitter: http://twitter.com/foundmyfitness ▶︎ Facebook: http://www.facebook.com/foundmyfitness ▶︎ Instagram: http://www.instagram.com/foundmyfitness
Views: 150127 FoundMyFitness
Understanding the mechanisms of venetoclax and ibrutinib resistance
 
01:33
We need to understand the mechanisms of drug resistance in order to prevent it, in addition to informing subsequent treatment decisions. In this interview, Constantine Tam, MD, FRACP, FRCPA, of Peter MacCallum Cancer Centre, Melbourne, Australia, discusses our current knowledge of the mechanisms of resistance to venetoclax and ibrutinib. He highlights how, interestingly, the usual mutation of the primary therapeutic target has not been found in venetoclax resistant patients thus far. This video was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.
Intestinal Stem Cells and Colon Cancer: Biology to Therapy
 
02:51
This AACR Special Conference to beheld September 27-30, 2018, in Washington, D.C. will appeal to students, fellows, scientists, physicians, and others. The conference will feature the latest research, resulting in opportunities for translation into new avenues for early detection, risk stratification, and innovative therapies including both targeted therapeutics and immunotherapeutics. Learn more at www.AACR.org/Colon18.
Family Recovery From Substance Abuse - Part 2 - LastingRecovery.com - with Judy Saalinger
 
13:22
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 2 of a 2-part Audio Program focusing on Family Recovery, with Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 246 Lasting Recovery
Prof. Charles Grob - Psilocybin-Therapy at the end of Life with Cancer-Patients (ITC 2017 Prague)
 
46:17
http://www.itcprague2017.org/speakers/charles-grob & http://www.freiraum-institut.ch/ This talk will present the findings of a pilot research investigation conducted at Harbor-UCLA Medical Center and the Los Angeles BioMedical Research Institute examining the safety and efficacy of psilocybin treatment in patients with advanced-stage cancer anxiety. This study, funded by the Heffter Research Institute, was the first formal effort in several decades designed to re-examine early promising findings using a psychedelic treatment model to address the psychospiritual demoralization often encountered by individuals with terminal cancer. The significance of observations made by psychedelic research pioneers, including Stanislav Grof and Walter Pahnke, will be described as will the background, methodological design and results of contemporary investigations of psilocybin treatment. Particular examination will be made of safety parameters as well as potential mechanisms for observed therapeutic outcomes. Medical and cultural implications to developing a psychedelic treatment model at the end of life will be explored. Charles S. Grob, M.D. is Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center, and Professor of Psychiatry and Pediatrics at the UCLA School of Medicine. Dr. Grob conducted the first government approved psychobiological research study of MDMA, and was the principal investigator of an international research project in the Brazilian Amazon studying the visionary plant brew, ayahuasca. He has also completed and published the first approved research investigation in several decades on the safety and efficacy of psilocybin treatment in terminal cancer patients with anxiety. And, he has recently completed a pilot investigation into the use of an MDMA treatment model for social anxiety in autistic adults. Dr. Grob is the editor of Hallucinogens: A Reader (Tarcher/Putnam, 2002) and co-editor (with Roger Walsh) of Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics (SUNY Press, 2005). He is also a founding board member of the Heffter Research Institute. #Psilocybin #CharlesGrob #Research Source: ITC-Prague 2017 freiraum-Institute is an official Supporter of the ITC 2017
Views: 278 Jörg Fuhrmann
Chronic Pain & Opiate Dependence Part 2 - LastingRecovery.com - San Diego - Judy Saalinger
 
15:08
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 2 of a 3-part Audio Program focusing on Chronic Pain & Opiate Dependency, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 178 Lasting Recovery
Substance Use, Abuse and Addiction - Part 1 - LastingRecovery.com - Judy Saalinger
 
14:59
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 1 of a 3-part Audio Program focusing on Substance Use, Abuse and Addiction - What's the Difference?, with Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 356 Lasting Recovery
Discussing 'Relapse' - LastingRecovery.com - Judy Saalinger
 
03:27
Judy Saalinger, Co-Founder and Executive Director of San Diego's premier alcohol and drug addiction treatment center Lasting Recovery, shares "Discussing 'Relapse'". For more information visit lastingrecovery.com, or call 858-453-4315. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 201 Lasting Recovery
What Is Cross Addiction? - LastingRecovery.com - Judy Saalinger
 
03:57
Judy Saalinger, Co-Founder and Executive Director of San Diego's premier alcohol and drug addiction treatment center Lasting Recovery, explains "Cross Addiction" For more information visit lastingrecovery.com, or call 858-453-4315. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315 Category Education License Standard YouTube License
Views: 176 Lasting Recovery
Prescription Drug Abuse Part 1 - LastingRecovery.com - San Diego - Judy Saalinger
 
20:46
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 1 of a 3-part Audio Program focusing on PRESCRIPTION DRUG ABUSE, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 179 Lasting Recovery
Ending the arms race with infectious diseases | Janelle Ayres | TEDxSanDiego
 
13:36
There is a disconnect between our methods for treating infectious diseases and our understanding of the mechanisms that keep us healthy during infection. Infections cause significant damage to our bodies and limiting this damage, together with pathogen eradication, ultimately determines whether or not a patient will survive. In her talk Dr. Janelle Ayres discusses strategies using the human microbiome to develop new therapeutics for promoting survival of infectious disease that will overcome the arms race between us and infections. Dr. Ayres’ research program is focused on developing new strategies for treating both infectious and non-infectious disease. She is especially interested in leveraging our interactions with the microbiome–the trillions of good bacteria living on our bodies–to end the arms race with infectious diseases and antibiotic resistance. Dr. Ayres earned her PhD from Stanford University School of Medicine in Microbiology and Immunology. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Views: 2852 TEDx Talks
Prescription Drug Abuse Part 2 - LastingRecovery.com - San Diego - Judy Saalinger
 
16:35
Visit LastingRecovery.com or call 858-453-4315 to find the help you need. Part 2 of a 3-part Audio Program focusing on PRESCRIPTION DRUG ABUSE, with Dr. Judy Saalinger of Lasting Recovery, the premiere San Diego outpatient treatment center. Judy Saalinger, Ph.D., MFT, CAS, and Arthur Farkas, Ph.D., founded Lasting Recovery in July, 2004. With well over 30 years of therapeutic and clinical work in the field and many years of personal recovery from addictions, the husband and wife team recognized an opportunity for their work to have an even greater impact while addressing the unmet need for quality outpatient addiction treatment in San Diego. Lasting Recovery's History: •July 2004 - Opened the doors to Lasting Recovery for Outpatient Treatment •January 2005 --Certified by California Alcohol and Drug Programs •January 2010 -- Awarded CARF Accreditation •May 2010 --TRICARE Certified Substance Use Disorder Rehab Facility (SUDRF) We work with individuals and families and offer hope for a healing recovery and a promising future. We coordinate care with psychiatrists, therapists, psychologists, family and primary care physicians, facilities, attorneys, employers, universities and diversion boards through confidential, professional assistance with education, referrals, and placement services. We refer to: •Interventionists •Inpatient detoxification and treatment facilities •Transitional/ sober living homes •Psychiatrists •Psychotherapists •Primary care physicians Lasting Recovery also acts as a step down level of care for patients discharging from inpatient treatment facilities, by providing half and full day partial hospitalization, intensive outpatient care, aftercare, family groups and psychotherapy to help the individual and their family implement discharge plans outlined in inpatient treatment. 12540603 Holistic Wellness, Fearless Change Process, Family Program, Aftercare Group Support, Drug & Alcohol Assessments, Out-of-State Driving Under the Influence (DUI), Individual and Family Counseling, Intervention Information, Understanding Detoxification, San Diego, Hillcrest, California, KGTV Judy Saalinger is a California licensed Marriage & Family Therapist, (MFT), and a Certified Addiction Specialist (CAS), through the American Academy of Healthcare Providers in the Addictive Disorders. She facilitates psychoeducational groups in the Daytime Women's and Evening Co-Ed treatment programs. Prior to forming /establishing Lasting Recovery in 2004, Dr. Saalinger was in private practice for 23 years specializing in chemical dependency, depression, trauma, and anxiety-related issues for individuals and their families. She is the author of the FEARLESS CHANGE program curriculum. Find out more at Lastingrecovery.com or by calling 858-453-4315
Views: 58 Lasting Recovery
Mayo Clinic Endoxifen Study
 
03:53
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity. Mayo Clinic oncologist and lead author of the study Matthew Goetz, M.D., says, "We achieved up to sixtyfold higher levels of endoxifen compared to endoxifen levels achieved with the standard dose of tamoxifen. We have seen evidence for tumor regression in patients who had failed standard hormonal therapies including aromatase inhibitors, fulvestrant and tamoxifen. This is an exciting first step in the development of this drug." The findings indicate that Z-endoxifen, codeveloped by Mayo Clinic Cancer Center and the National Cancer Institute (NCI), may provide a new and better treatment for some women with estrogen positive breast cancer, and in particular for those who women who do not respond to tamoxifen and aromatase inhibitors. Results are being presented during the 2013 San Antonio Breast Cancer Symposium.
Views: 1066 Mayo Clinic